{"id":"W3028905201","doi":"10.1200/jco.2020.38.15_suppl.8015","title":"Acalabrutinib (Acala) versus idelalisib plus rituximab (IdR) or bendamustine plus rituximab (BR) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): ASCEND final results.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saint John Regional Hospital; University of New Brunswick","funders":"","keywords":"Medicine; Lenalidomide; Bendamustine; Internal medicine; Chronic lymphocytic leukemia; Hazard ratio; Progression-free survival; Gastroenterology; Rituximab; Oncology; Leukemia; Multiple myeloma; Overall survival; Confidence interval; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002330868,0.001005307,0.001361869,0.0005079529,0.0002946586,0.000754611,0.0009073624,0.001075308,0.003197469],"category_scores_gemma":[0.001240931,0.0003826999,0.001395831,0.0003815481,0.0006521238,0.0008111012,0.0003443317,0.002604705,0.0005993616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001147896,"about_ca_system_score_gemma":0.001234125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001050012,"about_ca_topic_score_gemma":0.003339904,"domain_scores_codex":[0.9994937,0.0002975576,0.0000318696,0.00005473796,0.00004337776,0.00007883176],"domain_scores_gemma":[0.9990031,0.0002716587,0.0002361911,0.00004323449,0.00004459385,0.0004013328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9196653,0.01251729,0.002434471,0.0004955443,0.0009868848,0.00008814382,0.0000826125,0.001535119,0.00726305,0.0001880118,0.004048577,0.05069486],"study_design_scores_gemma":[0.6352287,0.3431429,0.01079549,0.00008992164,0.001637451,0.0002026947,0.000054202,0.002102586,0.002612339,0.0003221324,0.003777226,0.00003425566],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872733,0.005445547,0.0004395254,0.0007396298,0.0002197573,0.001415906,0.001368963,0.0001067159,0.002990647],"genre_scores_gemma":[0.9909585,0.002160085,0.001000014,0.0009735607,0.0002682091,0.001038992,0.001863315,0.0000224006,0.001715064],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003197469,"threshold_uncertainty_score":0.01232696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2755138791443671,"score_gpt":0.4800903293985233,"score_spread":0.2045764502541561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}